Seizure outcome in drug-resistant epilepsy in the setting of polymicrogyria

Thandar Aung1, Jin Bo2, William Bingaman3

  • 1Epilepsy Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk S60, Cleveland, OH 44195, United States; University of Pittsburgh Epilepsy Center, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.

Seizure
|September 8, 2024
PubMed
Abstract

Insights

Intracranial electroencephalography (ICEEG)-guided surgery for polymicrogyria (PMG)-related drug-resistant epilepsy (DRE) improves seizure freedom. Identifying the epileptogenic zone (EZ) within or outside the PMG is key for successful surgical outcomes.

Area of Science:

  • Neuroscience
  • Epileptology
  • Neurosurgery

Background:

  • Polymicrogyria (PMG) is a cortical malformation associated with drug-resistant epilepsy (DRE).
  • Defining the precise epileptogenic zone (EZ) in PMG-related DRE is challenging, impacting surgical planning and outcomes.
  • Intracranial electroencephalography (ICEEG) offers detailed ictal onset localization.

Purpose of the Study:

  • To analyze seizure outcomes in patients with PMG-related DRE.
  • To define the ictal onset using ICEEG, considering surrounding cortex and surgical resection extent.
  • To identify predictors of seizure freedom (SF) in this patient cohort.

Main Methods:

  • Retrospective study of 35 patients with PMG-related DRE (2001-2018).
  • Primary outcome: complete seizure freedom (SF) via Engel classification (≥1 year follow-up).
  • Univariate and multivariate Cox proportional hazards models used to identify predictive clinical variables.

Main Results:

  • In the surgical group (n=23), 52% achieved SF, compared to 0% in the non-resective group (n=12) (p=0.002).
  • Seizure freedom was not significantly different based on PMG laterality, perisylvian involvement, or resection extent (total vs. partial).
  • Patients with ictal onset in both PMG and non-PMG cortices, or only non-PMG cortices, had better SF chances than those with onset solely within PMG cortices.

Conclusions:

  • Resective surgery guided by ICEEG for EZ definition in PMG-related DRE leads to favorable seizure outcomes.
  • ICEEG-guided focal resections can achieve SF even in complex PMG cases (bilateral or extensive unilateral).
  • Complete resection of MRI-visible PMG does not guarantee SF; preimplantation hypothesis development based on epileptogenic network evaluation is crucial.

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
150
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
349
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
181
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
273
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
300
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
309